응급구조사들이 사용하는 약물의 제형 개발에 관한 연구 = A study on easy-to-use drug formulation for emergency medical technicians

다국어 초록 (Multilingual Abstract)

Purpose: In this study we aimed to manufacture and evaluate an oral disintegrating film containing ibuprofen.
Methods: Optimal oral ventilation was manufactured using ibuprofen 3g, polyvinyl alcohol #500 4.2g, HPMC K 100M 1.6g, glycerol 4g, TWEEN #20 0.3g, PEG #20 0.3g, citric acid 0.5g, sucralose 0.1g, ethamol 10mL, and distilled water 30mL.
Results: Film mass ranged from 110 to 130mg in all prescriptions, showing general uniformity while the water content ranged from 6 to 12%. Measurement of ibuprofen content in all manufactured film solutions averaged 100.12% (98.0-102.0%). The elution test predicted the time taken from the body and the film agent of all prescriptions was released 100% within 5 minutes to confirm the rapid elution.
Conclusion: Based on the results of all test, prescription E was proved to be the most suitable.

참고문헌 (Reference)

1 나승민, "파 에너지 (자외선, 초음파)/과황산나트륨을 이용한 이부프로펜 분해특성 연구" 한국환경과학회 23 (23): 963-972, 2014

2 여미순, "키랄 고성능 액체 크로마토그래피를 이용한 이부프로펜의 분리도에 관한 실험식" 한국생물공학회 18 (18): 261-265, 2003

3 김경수, "비스테로이드성 항염증 약물의 임상적 이용" 대한이비인후과학회 47 (47): 91-98, 2004

4 백종섭, "뇌졸중 예방 및 치료를 위한 가미보양환오탕 구강붕해정 제형 연구" 한국약제학회 39 (39): 445-449, 2009

5 Lee JW, "Solubilization of ibuprofen in aqueous solution" 27 (27): 279-286, 1997

6 Baek SW, "Solubility and crystallization of ibuprofen in the presence of various solvents and antisolvents" Kyungpook National university 2017

7 Choi JH, "Self-emulsifying drug delivery system containing ibuprofen for oral use" 29 (29): 99-103, 1999

8 Kim H, "Quantitation of flurbiprofen in isopropyl myristate by high performance liquid chromatography" 22 (22): 63-68, 1992

9 Prajapati ST, "Preparation and evaluation of sublingual tablets of zolmitriptan" 4 (4): 27-31, 2014

10 Shin KH, "Preparation and evaluation of flurbiprofenand flurbiprofen axetil-loaded microemulsion" 41 (41): 607-614, 1997

11 이영빈, "Orally disintegrating films focusing on formulation, manufacturing process, and characterization" 한국약제학회 47 (47): 183-201, 2017

12 Gopinath R, "Oral disintegrating tablets-A current review" 4 (4): 1134-1154, 2013

13 Rhee GJ, "Formulation and pharmaceutical properties of mucoadhesive film containing dipotassium glycyrrhizate" 29 (29): 127-136, 1999

14 Bansal S, "Formulation and evaluation of fast dissolving film of an antithypertensive drug" 3 (3): 1097-1108, 2013

15 Yong CS, "Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and Menthol" 269 (269): 169-176, 2004

16 Lee GW, "Development and evaluation of orodispersible films for oro-mucosal application" 14 (14): 47-54, 2016

17 Yang HJ, "Comparative single-dose pharmacokinetics of sildenafil after oral and rectal administration in healthy beagle dogs" 14 : 291-, 2018

18 Kim MJ, "COX-2 Inhibitor" 1 (1): 79-88, 2002

19 Arun JL, "Buccal drug delivery system : history and recent developments" 19 : 1-7, 2016

20 Bushra N, "An overview of clinical pharmacology of ibuprofen" 25 (25): 155-161, 2010